Knockdown of NSBP1 was associated with reduced cell proliferation and growth in vivo in prostate cancer [44], inhibition of invasion in ccRCC [25], inhibition of EMT in bladder cancer [42] and reduced proliferation and invasion in NSCLC [43]. Here, HMGN5 is linked to nonpapillary renal cell carcinoma.